<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wikidot="http://www.wikidot.com/rss-namespace">

	<channel>
		<title>Brachytherapy for Intermediate Risk Prostate Cancer</title>
		<link>http://isocentre.wikidot.com/forum/t-256449/brachytherapy-for-intermediate-risk-prostate-cancer</link>
		<description>Posts in the discussion thread &quot;Brachytherapy for Intermediate Risk Prostate Cancer&quot;</description>
				<copyright></copyright>
		<lastBuildDate>Fri, 15 May 2026 17:06:59 +0000</lastBuildDate>
		
					<item>
				<guid>http://isocentre.wikidot.com/forum/t-256449#post-869760</guid>
				<title>Re: Brachytherapy for Intermediate Risk Prostate Cancer</title>
				<link>http://isocentre.wikidot.com/forum/t-256449/brachytherapy-for-intermediate-risk-prostate-cancer#post-869760</link>
				<description></description>
				<pubDate>Sat, 11 Sep 2010 00:19:38 +0000</pubDate>
				<wikidot:authorName>Rohit Malde</wikidot:authorName>				<wikidot:authorUserId>418807</wikidot:authorUserId>				<content:encoded>
					<![CDATA[
						 <p>Nikhilesh,</p> <p>The debate i believe in this risk group is whether EBRT + Brachy is superior to EBRT alone or Brachy alone.</p> <p>1. Hoskin et al have already shown in Ph 3 trial, that EBRT + Brachy boost is superior to RT alone.<br /> <a href="http://cat.inist.fr/?aModele=afficheN&amp;cpsidt=19038384">http://cat.inist.fr/?aModele=afficheN&amp;cpsidt=19038384</a></p> <p>2. The RTOG 0232 are proposing to prove that EBRT + Brachy alone is gnna be superior to Brachy alone.<br /> If you look at their statistcal proposotion they beleive EBRT plus interstitial brachytherapy will improve a FFP rate at 5 years<br /> compared to interstitial brachytherapy alone by 10% with an α value of 0.025 (one-sided), statistical power of 90%.</p> <p>This trial is gonna be controversial as Brachy alone is being used here as the std arm<br /> and the experimental arm is EBRT + Brachy which allows IMRT as well as 3DCRT.</p> 
				 	]]>
				</content:encoded>							</item>
					<item>
				<guid>http://isocentre.wikidot.com/forum/t-256449#post-869745</guid>
				<title>Re: Brachytherapy for Intermediate Risk Prostate Cancer</title>
				<link>http://isocentre.wikidot.com/forum/t-256449/brachytherapy-for-intermediate-risk-prostate-cancer#post-869745</link>
				<description></description>
				<pubDate>Fri, 10 Sep 2010 23:48:45 +0000</pubDate>
				<wikidot:authorName>Nikhilesh Patil</wikidot:authorName>				<wikidot:authorUserId>416151</wikidot:authorUserId>				<content:encoded>
					<![CDATA[
						 <p>Iam still waiting for people to tell me if you guys offer brachytherapy for intermediate risk prostate cancer patients.</p> 
				 	]]>
				</content:encoded>							</item>
					<item>
				<guid>http://isocentre.wikidot.com/forum/t-256449#post-840584</guid>
				<title>Brachytherapy for Intermediate Risk Prostate Cancer</title>
				<link>http://isocentre.wikidot.com/forum/t-256449/brachytherapy-for-intermediate-risk-prostate-cancer#post-840584</link>
				<description></description>
				<pubDate>Sun, 01 Aug 2010 05:36:00 +0000</pubDate>
				<wikidot:authorName>Nikhilesh Patil</wikidot:authorName>				<wikidot:authorUserId>416151</wikidot:authorUserId>				<content:encoded>
					<![CDATA[
						 <p>Dear all,<br /> I would like to know your thoughts about Brachytherapy alone for good Intermediate Risk Prostate Cancer patients. Anyone of you using brachy alone for these patients. Iam aware of RTOG 0232 study <a href="http://rtog.org/members/protocols/0232/0232.pdf">http://rtog.org/members/protocols/0232/0232.pdf</a> which is looking at this question.<br /> Your comments are welcome<br /> Nikhilesh</p> 
				 	]]>
				</content:encoded>							</item>
				</channel>
</rss>